Tianjin TEDA Biomedical Engineering (8189.HK) Earnings Analysis
Tianjin TEDA Biomedical Engineering (8189.HK) has no confirmed upcoming earnings date. Trailing P/E -1.99.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 8189.HK next report earnings?
No confirmed upcoming earnings date is currently scheduled for 8189.HK. This page updates as the calendar is published.
8189.HK earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2024-08-30 | -0.00117 HKD | n/a | n/a | n/a |
8189.HK valuation and analyst view
| Trailing P/E | -1.99 |
|---|---|
| Trailing EPS | -0.0631 HKD |
| Price / book | 21.31 |
| Dividend yield | 0.00% |
| Market cap | 0.31B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Tianjin TEDA Biomedical Engineering (8189.HK)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 8189.HK. This page updates as the calendar is published.
Did 8189.HK beat earnings last quarter?
Consensus estimate data was not available for 8189.HK's 2024-08-30 report.
What is 8189.HK's current P/E ratio and EPS?
8189.HK trades at a trailing P/E of -1.99 on trailing EPS of -0.06310428377992201 HKD.
What do analysts rate 8189.HK?
8189.HK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.